Keyphrases
Liraglutide
100%
Randomized Trial
100%
Placebo
100%
Weight Reduction
100%
Serum Creatinine
66%
Weight Loss
50%
Pre-diabetes (pre-DM)
33%
Diabetes
33%
Baseline Creatinine
33%
Type 2 Diabetes Mellitus (T2DM)
33%
Obesity
33%
Creatinine
16%
Change in Weight
16%
Kidney Function
16%
Treatment Group
16%
Estimated Glomerular Filtration Rate
16%
Body Weight Reduction
16%
Non-associated
16%
Randomized Double-blind Trial
16%
Weight Change
16%
AIMS™
16%
Nursing and Health Professions
Liraglutide
100%
Post Hoc Analysis
100%
Placebo
100%
Creatinine Blood Level
66%
Creatinine
50%
Impaired Glucose Tolerance
33%
Non Insulin Dependent Diabetes Mellitus
33%
Estimated Glomerular Filtration Rate
16%
Body Weight
16%
Treatment Group
16%
Pharmacology, Toxicology and Pharmaceutical Science
Creatinine
100%
Liraglutide
85%
Placebo
85%
Non Insulin Dependent Diabetes Mellitus
28%
Impaired Glucose Tolerance
28%
Treatment Group
14%
Immunology and Microbiology
Kidney Function
100%
Creatinine Blood Level
100%
Glomerulus Filtration
25%
Body Weight
25%